Dapsone-induced methemoglobinemia in leprosy patients.
Kaur
I
I
Mehta
M
M
Agnihotri
N
N
Dogra
S
S
Ganguly
N K
NK
D000293:Adolescent; D000328:Adult; D002648:Child; D003579:Cytochrome Reductases / Q000378:metabolism; D042966:Cytochrome-B(5) Reductase; D003622:Dapsone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000201:enzymology; D008875:Middle Aged
D007917:Leprostatic Agents; D003622:Dapsone; D003579:Cytochrome Reductases; D042966:Cytochrome-B(5) Reductase